IVD MEDICAL (01931): Build a "global enhanced version of Ethereum (ETH) treasury", upgrade the company's global strategy, and create value for ecological participants.

IVD MEDICAL (01931) announcement, the group's latest strategic upgrade and enhancement measures-the board of directors resolved to officially launch the "Enhanced Global Ethereum (ETH) Treasury with Downside Protection Mechanism" strategy (Ethereum (ETH) Treasury Strategy). The board of directors hereby announces that the "NewCo + RWA" Web3 Exchange has been officially named "ivd.xyz" (ivd.xyz Exchange), the ecosystem of the "NewCo + RWA" Web3 Exchange focused on high-tech assets in global medical innovation drugs is the "ivd.xyz Exchange ecosystem". To accommodate the large-scale commercial application of the group's medical innovation drug asset tokenization (RWA) and the IVDD stablecoin within the ivd.xyz Exchange ecosystem, all aspects of the group's RWA issuance, trading, settlement, and ecosystem governance are deeply integrated into the Ethereum ecosystem. Therefore, Ethereum (ETH) serves both as the underlying fuel and core reserve asset, with a continuous and scalable rigid demand for Ethereum (ETH). In compliance with applicable laws and regulations and the Securities Listing Rules of the Stock Exchange of Hong Kong, the company believes that by further upgrading the original diversified asset allocation and innovative drug RWA strategy, with Ethereum (ETH) as the core hub, creating a globally enhanced version of the Ethereum (ETH) Treasury with multiple downside protection mechanisms can maximize the number of Ethereum (ETH) per share of the company's stock, reduce systemic risks, and lead the traditional medical industry capital to efficiently cross over to the Web3 chain finance new paradigm. To protect the interests of shareholders, RWA holders, and potential investors, the board of directors has authorized management to build the following "verifiable, executable, and quantifiable" seven-fold mechanism while complying with applicable laws and regulations and listing rules: 1. ATM (At-The-Market) mechanism; 2. Senior and junior layering structure; 3. RWA price repurchase commitment; 4. Clinical VC underpinning mechanism; 5. Ethereum (ETH) derivatives hedging; 6. Dollar-cost averaging strategy; 7. Share repurchase plan. In order to continuously lead in terms of reserve scale, profit thickness, and capital efficiency in the "Enhanced Global Ethereum (ETH) Treasury" strategic process, the board of directors has authorized management to construct an additional "three-tier enhancement engine" based on the existing seven-fold downside protection, while complying with applicable laws and regulations and listing rules. This engine is based on a positive cycle of "pledge-finance-repledge", with an overlay of "interest-options" dual-wheel profit amplifier, and introduces top-tier quantitative management genes through "mergers + delegations", achieving a qualitative change in Ethereum (ETH) assets from "passive hoarding" to "active interest-bearing, reinvestment, and expansion". In the process of promoting the "Enhanced Global Ethereum (ETH) Treasury" strategy, the group has systematically combed and focused on the leading practices in the global cryptocurrency asset reserve field, especially focusing on the models of US-listed companies MicroStrategy, Bitmine Immersion Tech, SharpLink Gaming, Japanese-listed company Metaplanet, and Hong Kong-listed company BOYAA in Ethereum (ETH) asset allocation and strategic management areas. These leading practices provide important market references for the group to formulate the "Enhanced Global Ethereum (ETH) Treasury" strategy. Furthermore, the evolution path of the Ethereum community and its technical ecosystem, especially the technical concepts proposed by Ethereum founder Vitalik Buterin (V God), as well as the contributions of Dr. Xiao Feng, an important supporter of Ethereum, in ecosystem construction, provide key references for the group to understand the underlying logic of blockchain technology and the development laws of the ecosystem. In addition, the practices of institutions such as HashKey Group in the compliance process also provide valuable experience for the group to build a compliance framework. In addition, the design of the group's strategic model fully considers the mature practices of the above-mentioned entities in Ethereum (ETH) and other encrypted asset reserve management, technical ecosystem construction, and compliance operations, and combines with the particularity of the medical innovation drug industry for adaptive innovation. IVD MEDICAL will be based on medical innovation professionalism and financial innovation practice, systematically enhance the research and development efficiency of medical innovation drugs and capital allocation efficiency, and jointly write a new chapter of value in the era of chain finance.